我国县级公立医院补偿机制改革的路径选择(一)

县级公立医院是我国公立医院改革的突破口,而补偿机制是我国县级公立医院改革的切入点。梳理西方国家公立医院补偿机制的改革现状和发展趋势,为我国县级公立医院补偿机制改革的路径选择提供借鉴。对比我国县级公立医院补偿机制改革的理论路线和政策选择,为我国县级公立医院补偿机制改革的路径选择寻找出路。     

对县级公立医院补偿机制改革的概念分析(三)

县级公立医院是我国公立医院改革的突破口,而补偿机制是我国县级公立医院改革的切入点。将公立医院补偿机制改革试点的大概念分解为公立医院、补偿、机制、改革、试点五个小概念,并分别予以解构,力图揭示公立医院补偿机制改革试点的本质内涵和主要内容。     

公立医院补偿机制制度变迁与路径优化研究

补偿机制改革是公立医院改革的重点和难点,目前尽管强化公立医院的公益性,调整补偿机制等医疗改革已经开展,但是效果不是很明显.推进公立医院补偿机制改革有序、平稳、顺利的进行,已成为当前的一项重要课题.本文分析医院补偿机制的历史演进,考察我国公立医院补偿机制的现状及问题.在此基础上,并对目前补偿机制改革的动力及改革路径优化做出力所能及的思考.     

公立医院补偿机制改革的思考

文章阐述了新医改下补偿机制改革的意义,分析了公立医院补偿机制改革的难点,探讨了新医改形势下公立医院补偿机制改革的措施和对策.     

县级公立医院长效补偿机制的内容——县级公立医院补偿机制改革研究(四)

构建长效补偿机制是县级公立医院补偿机制改革的根本目标。对公立医院长效补偿机制的内容应该从补偿主体、补偿对象、补偿数量、补偿方式、补偿功能五个方面予以界定。补偿主体是指"谁补偿"公立医院的问题,补偿对象是指对公立医院"补偿什么"的问题,补偿数量是指对公立医院"补偿多少"的问题,补偿方式是指对公立医院"如何补偿"的问题,补偿功能是指对公立医院"为何补偿"的问题。正确解答这些问题,才能建构科学的县级公立医院长效补偿机制。     

完善公立医院补偿机制改革的难点与思考

补偿机制改革是公立医院改革的重点和难点。文章在分析当前公立医院财政补助现状以及取消药品加成的影响的基础上。指出当前补偿途径在具体实施过程中还存在相当的困难。为保障公立医院补偿机制改革的顺利推进,应从医疗服务的公平性和效益出发。明确补偿范围,制定补偿标准,并在机制体制上确保补偿到位。     

公立医院补偿机制改革宏观影响因素的政策情景分析

目的探析影响公立医院补偿机制的宏观因素,以期为解决我国目前补偿机制中存在的一些实际问题提供借鉴。方法运用PEST分析法,从政策环境、经济环境、社会环境和技术环境4类影响公立医院发展尤其是影响公立医院补偿机制的因素进行分析。结果公立医院补偿机制所处的宏观环境具有政治、经济、社会和技术上的优势,但是在国家改革、政策以及信息化水平等方面还需进一步的发展和完善。结论基于公立医院补偿机制的宏观影响因素分析,建议公立医院补偿机制改革需要从3个方面着手:确保政府财政补偿到位;完善医保支付制度,科学设置支付标准以及优化费用结算办法;合理利用医疗技术,完善医院信息管理服务平台。     

公立医院补偿机制探讨

完善补偿机制作为公立医院改革的重点和难点,所取得的成效将关乎新医改的成败。通过分析医改三年公立医院经济运行情况和患者的医疗负担,发现补偿机制改革中存在的问题;完善补偿机制,有利于公立医院改革的深入,实现缓解"看病贵,看病难"的目标。     

我国公立医院卫生财政补偿政策变迁及医院成本核算的战略意义

公立医院补偿机制改革与医院监管机制、药品监管机制、医疗保障体制改革密切相关。回顾了改革开放以来我国公立医院财政补偿政策变迁的3个阶段,并从公立医院职能的角度,分析了公立医院成本核算在界定医院财政补偿与市场补偿领域的重要意义。     

基于多机制框架的县级公立医院补偿机制设计

县级公立医院补偿机制的设计不单纯是一个财务的平衡问题,涉及政府、医保、医院、价格等多方面的机制协调。以公立医院补偿机制改革的经验借鉴为出发点,总结了县级公立医院补偿机制设计的基本逻辑和“多机制框架”。依据激励相容理论,对“多机制框架”下的县级公立医院补偿机制进行了系统设计。     

Compensation for general surgeons

Determining salary compensation for general surgeons is very complex for both private and academic-based physician practices. In this paper, the development of a plan for private practice general surgeons will be addressed.     

Compensation for failed sterilization

Two recent Court of Appeal decisions have modified the hitherto settled rules governing the compensation payable following failed and negligently performed sterilization. Compensation is now possible other than for the pain and suffering of the pregnancy where the child or mother is disabled.     

美国辐射相关疾病的补偿

美国作为核武器大国,其核工业及核武器研制人员疾病补偿受到了社会关注,补偿作为一种事后补救性保障手段得到了相关应用。本文主要从补偿覆盖的人群范围、补偿的病种范围、补偿的判定方法以及相关福利和补偿的金额或形式等方面概述了美国针对辐射相关疾病所建立的三种补偿计划。     

Compensation for harm: the implications for medical research.

The rising incidence of medical litigation in the 1980's led to a relatively minor modification in January 1990 of the United Kingdom's negligence-based system of medical compensation, as a result of which employing Health Authorities now accept full vicarious liability for the negligent (but not other) actions of employed clinicians (Crown indemnity). During the same period, by contrast, bodies such as the Royal College of Physicians have strongly influenced locally established Research Ethics Committees towards favouring no-fault compensation for harm resulting from medical research. The discordance between these two approaches to compensation has caused anxiety during the last year. There has been particular concern about the possible discouragement of non-commercially sponsored research. Hitherto however, no data has been available to inform this discussion. This paper reports the findings of a questionnaire survey of all research ethics committees in the United Kingdom (64% response rate), which indicates that 61% of committees require no-fault compensation for at least some projects and that 33% of these committees have rejected projects solely or mainly due to the lack of such provision. Rejection is significantly more common in Health Districts which contain teaching hospitals. Our critical analysis of the arguments advanced in favour of no-fault provision for research subjects suggests that they do not place adequate emphasis upon respect for the autonomy of individuals. We consider that it is in general more consistent with such respect fully to inform research subjects of the available compensation arrangements, rather than for ethics committees to make no-fault compensation a general requirement before ethical approval is given.